Follow along as we build a weight loss tracker in Google Sheets from scratch. You’ll learn how to enter goals, log progress, adjust charts, and print your tracker for an easy way to stay on top of ...

These players are vying for positions in the billion-dollar weight loss drug market. Demand for weight loss drugs is soaring, suggesting there's room for more than one winner. Investors once ...

Some women are experiencing significant hair loss as a side effect of testosterone therapy and popular weight-loss drugs. Rapid weight loss from GLP-1 medications like Ozempic and Zepbound can trigger ...

A pill form of the weight loss drug Wegovy was as effective as injections for people with obesity in a clinical trial, the drug's manufacturer said. Novo Nordisk said in its news release that ...

Pfizer PFE-3.43%decrease; red down pointing triangle has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera MTSR 1.16%increase; green up pointing triangle in a deal that gets the ...

While Ozempic and other drugs like it have proven effective in helping people lose weight, many gain it back when the injections stop. A new drug targets weight loss differently, leading to a more ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...

VIENNA — Exercise to maintain weight loss reduced atherosclerosis progression and improved cardiovascular biomarkers, while GLP-1 therapy alone didn’t, according to a randomized trial in people with ...

Novo Nordisk said that patients taking a pill form of Wegovy in a clinical trial lost about as much weight as those who get the shot version, fueling new optimism that oral GLP-1 drugs could expand an ...

A weekly dose of semaglutide at three times the currently approved level was associated with significant weight loss compared to both the currently approved dose and placebo, according to the results ...

Over the last four years, weight-loss drugs that dampen down appetite and promote satiety have revolutionised obesity medicine. They are currently being taken by 1.5 million people in the UK and have ...